These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23305315)

  • 21. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell penetrating peptide-mediated systemic siRNA delivery to the liver.
    Hayashi Y; Yamauchi J; Khalil IA; Kajimoto K; Akita H; Harashima H
    Int J Pharm; 2011 Oct; 419(1-2):308-13. PubMed ID: 21827843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles.
    Wong Y; Markham K; Xu ZP; Chen M; Max Lu GQ; Bartlett PF; Cooper HM
    Biomaterials; 2010 Nov; 31(33):8770-9. PubMed ID: 20709387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Multifunctional Envelope-Type Nano Device Containing a pH-Sensitive Cationic Lipid for Efficient Delivery of Short Interfering RNA to Hepatocytes In Vivo.
    Sato Y; Harashima H; Kohara M
    Methods Mol Biol; 2016; 1364():71-8. PubMed ID: 26472443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PEGylation of 6-amino-6-deoxy-curdlan for efficient in vivo siRNA delivery.
    Altangerel A; Cai J; Liu L; Wu Y; Baigude H; Han J
    Carbohydr Polym; 2016 May; 141():92-8. PubMed ID: 26877000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
    Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
    Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
    Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
    Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging.
    Yu Q; Liu Y; Cao C; Le F; Qin X; Sun D; Liu J
    Nanoscale; 2014 Aug; 6(15):9279-92. PubMed ID: 24986368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
    Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
    J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
    Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
    Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient systemic delivery of siRNA to the mouse liver by pegylated lipopolymer.
    Liu J; Van S; Ma N; Yu L
    Int J Pharm; 2012 May; 427(1):58-63. PubMed ID: 22100515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
    Andersen MØ; Howard KA; Kjems J
    Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attacking the genome: emerging siRNA nanocarriers from concept to clinic.
    Alabi C; Vegas A; Anderson D
    Curr Opin Pharmacol; 2012 Aug; 12(4):427-33. PubMed ID: 22726555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic insights into LDL nanoparticle-mediated siRNA delivery.
    Jin H; Lovell JF; Chen J; Lin Q; Ding L; Ng KK; Pandey RK; Manoharan M; Zhang Z; Zheng G
    Bioconjug Chem; 2012 Jan; 23(1):33-41. PubMed ID: 22142191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.